可溶性特异物质在 II 型和 III 型肺炎球菌口服免疫中的作用。
THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III.
机构信息
Bureau of Laboratories, Department of Health of the City of New York, New York.
出版信息
J Exp Med. 1932 Jan 1;55(1):1-12. doi: 10.1084/jem.55.1.1.
Abstract
- When the soluble specific substance of Type II pneumococcus was fed to rats, little or no increased resistance to the organism was obtained. 2. When the specific substance of Type III pneumococcus was fed, an increased resistance to the virulent organism resulted. The percentage of animals protected is smaller than when the whole or the dissolved cell is fed. 3. When the specific polysaccharide of Type I was fed, no immunity against Type II or III was obtained, and the ingestion of the specific substances of Types II and III did not protect rats against the Type I organism.
摘要
- 将 II 型肺炎球菌的可溶性特异性物质喂给老鼠时，老鼠对该病原体的抵抗力几乎没有增加。2. 当 III 型肺炎球菌的特异性物质被喂食时，老鼠对毒性生物体的抵抗力增强。受保护动物的百分比比喂食整个或溶解的细胞时要小。3. 当喂食 I 型的特异性多糖时，没有获得针对 II 型或 III 型的免疫力，而且摄取 II 型和 III 型的特异性物质也不能保护老鼠免受 I 型生物体的侵害。
相似文献
1
THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III.可溶性特异物质在 II 型和 III 型肺炎球菌口服免疫中的作用。
J Exp Med. 1932 Jan 1;55(1):1-12. doi: 10.1084/jem.55.1.1.
2
THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I.针对 I 型肺炎球菌的口服免疫中可溶性特异物质的作用。
J Exp Med. 1931 Nov 30;54(6):899-923. doi: 10.1084/jem.54.6.899.
3
DECOMPOSITION OF THE CAPSULAR POLYSACCHARIDE OF PNEUMOCOCCUS TYPE III BY A BACTERIAL ENZYME.III 型肺炎球菌荚膜多糖的细菌酶降解。
J Exp Med. 1931 Jun 30;54(1):51-71. doi: 10.1084/jem.54.1.51.
4
THE FATE OF ORALLY ADMINISTERED SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS TYPES I, II AND III.口服型 I、II、III 型肺炎球菌可溶性特异性物质的命运。
J Exp Med. 1932 Jan 1;55(1):13-25. doi: 10.1084/jem.55.1.13.
5
STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.肺炎球菌生长抑制的研究：六、肺炎球菌可溶性物质对正常血清-白细胞混合物中肺炎球菌生长的特异性影响。
J Exp Med. 1926 Apr 30;43(5):633-45. doi: 10.1084/jem.43.5.633.
6
STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : III. INCREASED RESISTANCE TO TYPE III INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R AND S FORMS OF PNEUMOCOCCUS.肺炎球菌粘液型（III 型）免疫研究：III. 用 R 和 S 型肺炎球菌免疫接种诱导兔对 III 型感染的抵抗力增强。
J Exp Med. 1927 Jul 31;46(2):343-56. doi: 10.1084/jem.46.2.343.
7
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.肺炎球菌可溶性特异物质：第二篇论文。
J Exp Med. 1924 Aug 31;40(3):301-17. doi: 10.1084/jem.40.3.301.
8
ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III AND THE NORMAL VARIATION IN RESISTANCE TO THESE TYPES AMONG RATS.肺炎球菌 II 型和 III 型的口服免疫接种和大鼠对这些类型的正常抵抗力变异。
J Exp Med. 1931 Nov 30;54(6):875-98. doi: 10.1084/jem.54.6.875.
9
STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : II. CERTAIN DISTINGUISHING PROPERTIES OF TWO STRAINS OF PNEUMOCOCCUS TYPE III VARYING IN THEIR VIRULENCE FOR RABBITS, AND THE REAPPEARANCE OF THESE PROPERTIES FOLLOWING R-->S RECONVERSION OF THEIR RESPECTIVE ROUGH DERIVATIVES.肺炎球菌Ⅲ型天然免疫的研究：Ⅱ. 两种兔体毒力不同的肺炎球菌Ⅲ型菌株的某些鉴别特性，以及各自粗糙型衍生物 R-->S 回复突变后这些特性的再现。
J Exp Med. 1936 Jul 31;64(2):281-305. doi: 10.1084/jem.64.2.281.
10
AN IMMUNOLOGICAL STUDY OF THE A SUBSTANCE OR ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.肺炎球菌Ⅰ型荚膜多糖乙酰多聚物的免疫学研究。
J Exp Med. 1934 Jul 31;60(2):127-47. doi: 10.1084/jem.60.2.127.
引用本文的文献
1
THE FATE OF ORALLY ADMINISTERED SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS TYPES I, II AND III.口服型 I、II、III 型肺炎球菌可溶性特异性物质的命运。
J Exp Med. 1932 Jan 1;55(1):13-25. doi: 10.1084/jem.55.1.13.
本文引用的文献
1
THE FATE OF ORALLY ADMINISTERED SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS TYPES I, II AND III.口服型 I、II、III 型肺炎球菌可溶性特异性物质的命运。
J Exp Med. 1932 Jan 1;55(1):13-25. doi: 10.1084/jem.55.1.13.
2
THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I.针对 I 型肺炎球菌的口服免疫中可溶性特异物质的作用。
J Exp Med. 1931 Nov 30;54(6):899-923. doi: 10.1084/jem.54.6.899.
3
ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III AND THE NORMAL VARIATION IN RESISTANCE TO THESE TYPES AMONG RATS.肺炎球菌 II 型和 III 型的口服免疫接种和大鼠对这些类型的正常抵抗力变异。
J Exp Med. 1931 Nov 30;54(6):875-98. doi: 10.1084/jem.54.6.875.
Zotero 插件